You are here: Industry Insights > New data

News List

New Data Confirms Cardiac Dimensions' Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation prnasia
February 26, 2020
The data was presented in a late-breaking trials session at the Cardiovascular Research Technologies meeting (CRT 2020) in National Harbor, MD.
New data show Symbicort reduces attacks in mild asthma when used as an anti-inflammatory reliever worldpharmanews
May 24, 2019
New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential anti-inflammatory reliever in mild asthma.
New data reinforce effectiveness of Novartis’ Zolgensma for SMA pharmatimes
April 21, 2019
New AveXis data has reinforced the effectiveness of Novartis’ spinal muscular atrophy (SMA) Type I drug, Zolgensma (onasemnogene abeparvovec-xioi).
Gilead announces Novo Nordisk NASH partnership after new data revealed pharmatimes
April 16, 2019
Gilead Sciences has announced its intent to initiate a clinical collaboration with Novo Nordisk for a trial ……
Selvita to Present New Data from its Oncology Programs at the Upcoming SITC 2018 b3cnewswire
November 10, 2018
Data presented at the conference will include recent results from Selvita’s discovery phase project targeting cancer immunometabolism – a dual A2A/A2B adenosine receptor antagonist, as well as cancer immunotherapy – a novel class of small molecule direct
Merck's MS treatment shows promise in new data pharmatimes
May 03, 2018
New data published in The Multiple Sclerosis Journal has shown more promising results for Merck's MS treatment Mavenclad (cladribine tablets) on two subgroups of patients with highly active relapsing multiple sclerosis.